top of page

Tarsus' CEO on the launch XDEMVY and additional programs that will be reading out in 2024

Bobby Azamian provides an update on the commercial launch of XDEMVY in Demodex blepharitis, and discusses programs for Meibomian Gland Disease, rosacea, and Lyme disease.




Comments


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

bp-logo.png

Breakthrough Properties is a life science real estate company that is exclusively focused on delivering cutting-edge environments for the life science industry. With a portfolio of roughly 5 million square feet across the US, UK and continental Europe, Breakthrough has emerged as a leading partner for high-growth biotechs and pharmas around the world. 

bottom of page